|
RAB12 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.361200E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.831400E-04 |
| Normal-vs-Stage2 |
8.457500E-03 |
| Normal-vs-Stage3 |
3.253900E-02 |
| Normal-vs-Stage4 |
4.564300E-02 |
| Stage1-vs-Stage2 |
8.111200E-01 |
| Stage1-vs-Stage3 |
6.425600E-01 |
| Stage1-vs-Stage4 |
8.266600E-01 |
| Stage2-vs-Stage3 |
8.202200E-01 |
| Stage2-vs-Stage4 |
7.972600E-01 |
| Stage3-vs-Stage4 |
6.880000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.234990E-04 |
| Normal-vs-AfricanAmerican |
4.830100E-02 |
| Normal-vs-Asian |
7.574100E-02 |
| Caucasian-vs-AfricanAmerican |
5.637800E-02 |
| Caucasian-vs-Asian |
8.855800E-01 |
| AfricanAmerican-vs-Asian |
4.664600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.58259999999811E-05 |
| Normal-vs-Female |
5.021800E-02 |
| Male-vs-Female |
4.864100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.998800E-03 |
| Normal-vs-Extreme_Weight |
5.204700E-04 |
| Normal-vs-Obese |
3.464400E-03 |
| Normal-vs-Extreme_Obese |
5.915100E-03 |
| Normal_Weight-vs-Extreme_Weight |
4.527400E-01 |
| Normal_Weight-vs-Obese |
8.820200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.831400E-01 |
| Extreme_Weight-vs-Obese |
5.001800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.416800E-01 |
| Obese-vs-Extreme_Obese |
4.074400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.899550E-02 |
| Normal-vs-Age(41-60Yrs) |
1.307520E-02 |
| Normal-vs-Age(61-80Yrs) |
4.07310000000161E-05 |
| Normal-vs-Age(81-100Yrs) |
2.970200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.987400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.479400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.945000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.425700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.351600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.960200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.247630E-04 |
| Normal-VS-Type2 PRCC |
1.380480E-03 |
| Normal-VS-KIRP CIMP |
3.171200E-01 |
| Normal-VS-Unclassified PRCC |
4.795200E-03 |
| Type1 PRCC-VS-Type2 PRCC |
9.478200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.083400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.866200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.658200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.893200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.061600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.413830E-04 |
| Normal-vs-N1 |
8.406300E-02 |
| Normal-vs-N2 |
5.754000E-02 |
| N0-vs-N1 |
1.357990E-01 |
| N0-vs-N2 |
7.453800E-01 |
| N1-vs-N2 |
3.870400E-01 |
|
|
